(Q34642231)

English

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Pancras C.W. Hogendoorn

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

9

object named as

Jaap Verweij

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Peter Hohenberger

14

object named as

Peter Hohenberger

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sylvie Bonvalot

4

object named as

Sylvie Bonvalot

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

3

object named as

Axel Le Cesne

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Peter Reichardt

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Alberto Azzarelli

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Harald J Hoekstra

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Frits Van Coevorden

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Monia Ouali

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sandrine Marreaud

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Vivien H C Bramwell

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

EORTC Soft Tissue and Bone Sarcoma Group and the NCIC Clinical Trials Group Sarcoma Disease Site Committee

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

4 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1045-1054

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcom

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensified adjuvant IFADIC chemotherapy in combination with radiotherapy versus radiotherapy alone for soft tissue sarcoma: long-term follow-up of a prospective randomized feasibility trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide in the adjuvant therapy of soft tissue sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970346-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(12)70346-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22954508%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34642231&oldid=1732911153"